Moshkforoush, M., DeBeck, K., Brar, R., Fairbairn, N., Cui, Z., Milloy, M.-J., Buxton, J., Oldenburger, T., McLellan, W., Kendall, P., Sedgemore, K., Wilson, D., Kerr, T., & Hayashi, K. (2022). Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada. Harm Reduction Journal, 19(1), 50. https://doi.org/10.1186/s12954-022-00632-6
Glick, J. L., Grieb, S. M., Harris, S. J., Weir, B. W., Smith, K. C., Puryear, T., Hamilton White, R., & Allen, S. T. (2022). Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky. Harm Reduction Journal, 19(1), 47. https://doi.org/10.1186/s12954-022-00631-7
Brothers, T. D., Leaman, M., Bonn, M., Lewer, D., Atkinson, J., Fraser, J., Gillis, A., Gniewek, M., Hawker, L., Hayman, H., Jorna, P., Martell, D., O’Donnell, T., Rivers-Bowerman, H., & Genge, L. (2022). Evaluation of an emergency safe supply drugs and managed alcohol program in COVID-19 isolation hotel shelters for people experiencing homelessness. Drug and Alcohol Dependence, Prépublication, 109440. https://doi.org/10.1016/j.drugalcdep.2022.109440
Lew, B., Bodkin, C., Lennox, R., O’Shea, T., Wiwcharuk, G., & Turner, S. (2022). The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study. Harm Reduction Journal, 19(1), 29. https://doi.org/10.1186/s12954-022-00614-8
Schofield, J., Dumbrell, J., Matheson, C., Parkes, T., & Bancroft, A. (2022). The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study. BMC Public Health, 22(1), 500. https://doi.org/10.1186/s12889-022-12873-y
Mayfield, B. L., & Fogger, S. A. (2022). Risk Reduction Strategies for Adolescent Cannabis Use Considering COVID-19 Stressors. Journal of Addictions Nursing, 33(1), 45–50. https://doi.org/10.1097/JAN.0000000000000449
Bolinski, R. S., Walters, S., Salisbury-Afshar, E., Ouellet, L. J., Jenkins, W. D., Almirol, E., Van Ham, B., Fletcher, S., Johnson, C., Schneider, J. A., Ompad, D., & Pho, M. T. (2022). The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings. International Journal of Environmental Research and Public Health, 19(4), 2230. https://doi.org/10.3390/ijerph19042230
Behrends, C. N., Lu, X., Corry, G. J., LaKosky, P., Prohaska, S. M., Glick, S. N., Kapadia, S. N., Perlman, D. C., Schackman, B. R., & Des Jarlais, D. C. (2022). Harm Reduction and Health Services provided by Syringe Services Programs in 2019 and subsequent impact of COVID-19 on Services in 2020. Drug and Alcohol Dependence, Prépublication, 109323. https://doi.org/10.1016/j.drugalcdep.2022.109323
Parkes, T., Carver, H., Masterton, W., Booth, H., Ball, L., Murdoch, H., Falzon, D., Pauly, B. M., & Matheson, C. (2021). Exploring the Potential of Implementing Managed Alcohol Programmes to Reduce Risk of COVID-19 Infection and Transmission, and Wider Harms, for People Experiencing Alcohol Dependency and Homelessness in Scotland. International Journal of Environmental Research and Public Health, 18(23), 12523. https://doi.org/10.3390/ijerph182312523
Krawczyk, N., Fawole, A., Yang, J., & Tofighi, B. (2021). Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review. Addiction Science & Clinical Practice, 16(1), 68. https://doi.org/10.1186/s13722-021-00275-1
Canadian Association of People who Use Drugs. (2021). Overdose Prevention During a Pandemic. Zenodo. https://doi.org/10.5281/zenodo.5086337
Hout, M. C. V., Haddad, P., & Aaraj, E. (2021). The Impact of COVID-19 on Drug Use and Harm Reduction Programming in the Middle East and North Africa (MENA) Region: a Regional Consultation of Stakeholders and People Who Use Drugs. International Journal of Mental Health and Addiction, Prépublication. https://doi.org/10.1007/s11469-021-00500-7
Barnett, B. S., Wakeman, S. E., Davis, C. S., Favaro, J., & Rich, J. D. (2021). Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond. American Journal of Public Health, 111(6), 1013–1017. https://doi.org/10.2105/AJPH.2021.306228
Dumchev, K., Kiriazova, T., & Chernova, O. (2021). Impact of the COVID-19 epidemic on drug markets, substance use patterns, and delivery of harm reduction and treatment services in Ukraine. Addiction Research Center, Alternative Georgia. https://uiphp.org.ua/media/k2/attachments/2021-02-01_Ukraine_Covid.pdf
Kouimtsidis, C., Pauly, B., Parkes, T., Stockwell, T., & Baldacchino, A. M. (2021). COVID-19 Social Restrictions: An Opportunity to Re-visit the Concept of Harm Reduction in the Treatment of Alcohol Dependence. A Position Paper. Frontiers in Psychiatry, 12. https://doi.org/10.3389/fpsyt.2021.623649
Wenger, L. D., Kral, A. H., Bluthenthal, R. N., Morris, T., Ongais, L., & Lambdin, B. H. (2021). Ingenuity and Resiliency of Syringe Service Programs on the Front Lines of the Opioid Overdose and COVID-19 Crises. Translational Research, Prépublication. https://doi.org/10.1016/j.trsl.2021.03.011
Oberzil, V., & Schatz, E. (2021). Voices of frontline workers: harm reduction responses in the European region during the COVID-19 pandemic. Correlation – European Harm Reduction Network. http://fileserver.idpc.net/library/briefing-paper_Covid-report_final.pdf
Olding, M., Barker, A., McNeil, R., & Boyd, J. (2021). Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19. International Journal of Drug Policy, 90, 103076. https://doi.org/10.1016/j.drugpo.2020.103076
O’Carroll, A., Duffin, T., & Collins, J. (2021). Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland. International Journal of Drug Policy, 87, 102966. https://doi.org/10.1016/j.drugpo.2020.102966